Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.

Different antiviral activities of natural APOBEC3C, APOBEC3G, and APOBEC3H variants against hepatitis B virus.
Biochem Biophys Res Commun. 2019 Aug 07;:
Authors: Kanagaraj A, Sakamoto N, Que L, Li Y, Mohiuddin M, Koura M, Wakae K, Kurachi M, Muramatsu M, Kitamura K
Abstract
Some APOBEC3 family members have antiviral activity against retroviruses and DNA viruses. Hepatitis B virus (HBV) is a DNA virus that is the major causative factor of severe liver diseases such as cirrhosis and hepatocellular carcinoma. To determine whether APOBEC3 variants in humans have different anti-HBV activities, we evaluated natural variants of APOBEC3C, APOBEC3G, and APOBEC3H using an HBV-replicating cell culture model. Our data demonstrate that the APOBEC3C variant S188I had increased restriction activity and hypermutation frequency against HBV DNA. In contrast, the APOBEC3G variant H186R did not alter the anti-HBV and hypermutation activities. Among APOBEC3H polymorphisms (hap I-VII) and splicing variants (SV-200, SV-183, SV-182, and SV-154), hap II SV-183 showed the strongest restriction activity. These data suggest that the genetic variations in APOBEC3 genes may affect the efficiency of HBV elimination in humans.
PMID: 31400856 [PubMed - as supplied by publisher]

Source: Biochemical and Biophysical Research communications - August 6, 2019 Category: Biochemistry Authors: Kanagaraj A, Sakamoto N, Que L, Li Y, Mohiuddin M, Koura M, Wakae K, Kurachi M, Muramatsu M, Kitamura K Tags: Biochem Biophys Res Commun Source Type: research